Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥431.85B | ¥393.84B | ¥247.64B | ¥130.56B | ¥93.95B | ¥59.49B | ¥30.14B | ¥13.12B | ¥1.74B | ¥504.9M |
| Gross profit | — | — | — | ¥99.10B | ¥62.23B | ¥40.21B | ¥23.80B | ¥10.21B | ¥1.02B | −¥73.0M |
| Research & development | ¥16.50B | ¥12.66B | ¥10.95B | ¥10.38B | ¥8.99B | ¥6.89B | ¥3.87B | ¥1.12B | ¥129.2M | ¥29.4M |
| Operating expenses | ¥149.94B | ¥131.51B | ¥97.22B | ¥68.69B | ¥55.34B | ¥49.59B | ¥32.34B | ¥21.01B | ¥1.62B | ¥213.2M |
| Operating income | ¥93.10B | ¥108.42B | ¥58.70B | ¥30.40B | ¥6.90B | −¥9.38B | −¥8.54B | −¥10.80B | −¥595.7M | −¥286.2M |
| EBITDAderived | ¥93.70B | ¥109.13B | ¥59.48B | ¥32.63B | ¥8.39B | −¥8.73B | −¥7.90B | −¥10.30B | −¥593.5M | −¥285.5M |
| Net income | ¥97.84B | ¥112.43B | ¥60.03B | ¥31.54B | ¥7.77B | −¥7.18B | −¥6.97B | −¥10.22B | −¥525.1M | −¥292.0M |
| Basic EPSper diluted share | CN¥17.50 | CN¥20.31 | CN¥11.08 | CN¥6.24 | CN¥1.55 | -CN¥1.51 | -CN¥1.51 | -CN¥3.47 | -CN¥0.28 | -CN¥0.18 |
| Diluted EPSper diluted share | CN¥16.50 | CN¥19.00 | CN¥10.29 | CN¥5.48 | CN¥1.36 | -CN¥1.51 | -CN¥1.51 | -CN¥3.47 | -CN¥0.28 | -CN¥0.18 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 30, 2026Form 4 | Rietjens Ivonne MCMDirector | SellADSs | 560 | $99.59 | $55.8K | 0 |
| Mar 30, 2026Form 4 | Kam Anthony Ping LeungDirector | SellADSs | 1.5K | $99.43 | $152.4K | 0 |